Trial Profile
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Mecripyrine Hydrochloride Tablet
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Mecripyrine Hydrochloride (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors YenePharma
- 24 May 2018 New trial record